PMC:7299399 / 17093-17654
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T75 | 78-85 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T76 | 157-164 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T77 | 259-266 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T78 | 271-274 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T79 | 518-523 | Body_part | denotes | lipid | http://purl.org/sig/ont/fma/fma67264 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T180 | 60-62 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 27 |
| T181 | 75-77 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
| T182 | 191-192 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T183 | 251-252 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T104 | 78-85 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T105 | 157-164 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T106 | 253-257 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T107 | 259-266 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T108 | 518-523 | Chemical | denotes | lipid | http://purl.obolibrary.org/obo/CHEBI_18059 |
| T109 | 544-547 | Chemical | denotes | NPs | http://purl.obolibrary.org/obo/CHEBI_50803 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T25 | 117-123 | http://purl.obolibrary.org/obo/GO_0098739 | denotes | uptake |
| T26 | 117-123 | http://purl.obolibrary.org/obo/GO_0098657 | denotes | uptake |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T78 | 202-364 | Sentence | denotes | There are many issues related to the delivery of a drug, protein, or RNA into the patient as the cargo is often degraded, not bioavailable, or is swiftly cleared. |
| T79 | 365-491 | Sentence | denotes | Nanotechnology provides multiple solutions to these challenges though, as nanocarriers can overcome some of these limitations. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 259 | 51-59 | Species | denotes | patients | Tax:9606 |
| 261 | 284-291 | Species | denotes | patient | Tax:9606 |
| 266 | 518-523 | Chemical | denotes | lipid | MESH:D008055 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32519842-32259480-158486 | 60-62 | 32259480 | denotes | 27 |